Freeport-McMoRan
FCX · Copper
$65.18
0.9%Sherwin-Williams
SHW · Specialty Chemicals
$337.06
2.5%The short version
- Freeport-McMoRan is the larger business, with $25.9B of revenue in fiscal 2025 against $23.6B for Sherwin-Williams.
- Sherwin-Williams turned more of its sales into free cash flow (11.3% FCF margin, against 4.3% FCF margin).
- Sherwin-Williams earned a higher return on the capital invested in it (19.9%, against 12.1%).
- Investors pay more for each dollar of Freeport-McMoRan’s earnings: a P/E of 42.9x against 31.1x for Sherwin-Williams.
| Latest fiscal year | FCX · FY25 | SHW · FY25 |
|---|---|---|
| Size | ||
| Market cap | $94.1B | $82.9B |
| Revenue | $25.9B | $23.6B |
| Free cash flow | $1.1B | $2.7B |
| Net income | $2.2B | $2.6B |
| Growth | ||
| Revenue growth | 1.8% | 2.1% |
| 5-year growth | 12.8% | 5.1% |
| Share count change | −0.1% | −1.5% |
| Profitability | ||
| Gross margin | 28.2% | 48.9% |
| Operating margin | 25.2% | — |
| Net margin | 8.5% | 10.9% |
| FCF margin | 4.3% | 11.3% |
| Return on capital | 12.1% | 19.9% |
| Return on equity | 12.1% | 59.4% |
| Balance sheet | ||
| Net debt | $5.6B | $10.9B |
| Net debt / EBITDA | 0.6x | 2.4x |
| Dividends and buybacks | $972M | $2.4B |
| Valuation & quality | ||
| P/E | 42.9x | 31.1x |
| Piotroski F-score | 6 | 6 |
FY16
FCX $14.8B
SHW $11.9B
FY17
FCX $16.4B
SHW $15.0B
FY18
FCX $18.6B
SHW $17.5B
FY19
FCX $14.4B
SHW $17.9B
FY20
FCX $14.2B
SHW $18.4B
FY21
FCX $22.8B
SHW $19.9B
FY22
FCX $22.8B
SHW $22.1B
FY23
FCX $22.9B
SHW $23.1B
FY24
FCX $25.5B
SHW $23.1B
FY25
FCX $25.9B
SHW $23.6B
FCX
SHW
FY16
FCX −18.4%
SHW 18.3%
FY17
FCX 22.5%
SHW 14.9%
FY18
FCX 25.5%
SHW 14.9%
FY19
FCX 7.6%
SHW 15.7%
FY20
FCX 17.2%
SHW 18.4%
FY21
FCX 36.6%
SHW 15.5%
FY22
FCX 30.9%
SHW 15.3%
FY23
FCX 27.2%
SHW 18.1%
FY24
FCX 27.0%
SHW —
FY25
FCX 25.2%
SHW —
FCX
SHW
FY16
FCX $924M
SHW $1.1B
FY17
FCX $3.3B
SHW $1.7B
FY18
FCX $1.9B
SHW $1.7B
FY19
FCX −$1.2B
SHW $2.0B
FY20
FCX $1.1B
SHW $3.1B
FY21
FCX $5.6B
SHW $1.9B
FY22
FCX $1.7B
SHW $1.3B
FY23
FCX $455M
SHW $2.6B
FY24
FCX $2.4B
SHW $2.1B
FY25
FCX $1.1B
SHW $2.7B
FCX
SHW
FY16
FCX −10.9%
SHW 55.3%
FY17
FCX 18.9%
SHW 26.4%
FY18
FCX 15.8%
SHW 15.8%
FY19
FCX 2.2%
SHW 17.0%
FY20
FCX 4.9%
SHW 22.0%
FY21
FCX 23.8%
SHW 21.5%
FY22
FCX 18.0%
SHW 21.0%
FY23
FCX 13.1%
SHW 23.9%
FY24
FCX 13.3%
SHW 22.1%
FY25
FCX 12.1%
SHW 19.9%
FCX
SHW
Add another company
Compare up to four at once.
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.